Abstract: The invention relates to a method of predicting a subject's likelihood of being diagnosed with a malignant cancer, comprising measuring the relative expression level of a reference allele and an alternative allele of selected cancer risk associated polymorphisms in 17q22 in blood samples.
Type:
Application
Filed:
June 6, 2024
Publication date:
October 10, 2024
Applicant:
UNIVERSIDADE DO ALGARVE
Inventors:
Joana GONÇALVES DE GOUVEIA MAIA XAVIER, Ana Teresa LUÍS LOPES MAIA, Filipa Alexandra OLEIRO ESTEVES RIBEIROS
Abstract: The invention provides a method of identifying a subset of cancer patients with a poor prognosis, comprising comparing the allelic expression of a mutant and wildtype PIK3CA allele in a patient sample. The invention further teaches the use of drugs targeting the mutant PI3K protein in a subset of patients which are determined to express the a mutant PIK3CA allele above a certain threshold, in addition to a kit, or system with which PIK3CA allelic expression may be assessed.
Type:
Application
Filed:
September 3, 2023
Publication date:
February 29, 2024
Applicant:
UNIVERSIDADE DO ALGARVE
Inventors:
Ana Teresa LUÍS LOPES MAIA, Joana GONÇALVES DE GOUVEIA MAIA XAVIER, Lizelle WINKELSTRÖTER CORREIA, Ramiro Emanuel MAGNO MORGADO